Abstract
Fructose consumption per capita has increased markedly over the past decades and is thought to be related with the increased incidence of obesity and metabolic disorders worldwide. Fructose metabolism is mainly hepatic, for its first step at least, and does not require insulin. It was therefore initially thought to be of potential benefit in the dietary management of patients with impaired glucose homeostasis. Long term fructose administration, however, led to the development of hypertriglyceridemia in humans. In addition, it was associated with the development of impaired glucose homeostasis and high blood pressure in rodents. Stimulation of de novo lipogenesis is a major effect of dietary fructose. Recent evidence indicates that hepatic de novo lipogenesis may be directly linked to intrahepatic fat accumulation and hepatic insulin resistance. Furthermore, hyperlipidemia secondary to enhanced hepatic de novo lipogenesis may possibly lead to lipid accumulation in muscle and muscle lipotoxicity, thus resulting in impaired muscle glucose metabolism. This article reviews the present state of knowledge regarding the effects of fructose on whole body lipid metabolism and its possible relationship with the metabolic syndrome.
Keywords: Fructose, metabolic syndrome, insulin resistance, de novo lipogenesis, high blood pressure
Current Nutrition & Food Science
Title: Fructose Consumption, Lipid Metabolism and the Metabolic Syndrome
Volume: 2 Issue: 3
Author(s): Kim-Anne Le and Luc Tappy
Affiliation:
Keywords: Fructose, metabolic syndrome, insulin resistance, de novo lipogenesis, high blood pressure
Abstract: Fructose consumption per capita has increased markedly over the past decades and is thought to be related with the increased incidence of obesity and metabolic disorders worldwide. Fructose metabolism is mainly hepatic, for its first step at least, and does not require insulin. It was therefore initially thought to be of potential benefit in the dietary management of patients with impaired glucose homeostasis. Long term fructose administration, however, led to the development of hypertriglyceridemia in humans. In addition, it was associated with the development of impaired glucose homeostasis and high blood pressure in rodents. Stimulation of de novo lipogenesis is a major effect of dietary fructose. Recent evidence indicates that hepatic de novo lipogenesis may be directly linked to intrahepatic fat accumulation and hepatic insulin resistance. Furthermore, hyperlipidemia secondary to enhanced hepatic de novo lipogenesis may possibly lead to lipid accumulation in muscle and muscle lipotoxicity, thus resulting in impaired muscle glucose metabolism. This article reviews the present state of knowledge regarding the effects of fructose on whole body lipid metabolism and its possible relationship with the metabolic syndrome.
Export Options
About this article
Cite this article as:
Le Kim-Anne and Tappy Luc, Fructose Consumption, Lipid Metabolism and the Metabolic Syndrome, Current Nutrition & Food Science 2006; 2 (3) . https://dx.doi.org/10.2174/157340106778017823
DOI https://dx.doi.org/10.2174/157340106778017823 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-inflammatory Treatment of Acute Coronary Syndromes
Current Pharmaceutical Design Diet and Metabolic Syndrome: An Overview
Current Vascular Pharmacology Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study
Current Angiogenesis (Discontinued) Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Mental Health Patients at High Risk for Obesity, Type 2 Diabetes, and Cardiovascular Disease: An Australian Perspective
Current Hypertension Reviews Biological Activities of Three Extracts from Artedia squamata: A Study on Antioxidant and Enzyme Inhibitory Potential
Current Bioactive Compounds Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets Long-Term Multimodal Therapy (Verapamil Associated with Propolis, Blueberry, Vitamin E and Local Diclofenac) on Patients with Peyronie's Disease (Chronic Inflammation of the Tunica Albuginea). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Current Pharmaceutical Design Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Current Pharmaceutical Design Graphical Abstracts
Current Diabetes Reviews Apoptosis in Atherosclerosis: A Mini-Review
Mini-Reviews in Medicinal Chemistry The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas – A Case Report
Current Radiopharmaceuticals Soluble Epoxide Hydrolase: A Novel Target for the Treatment of Hypertension
Recent Patents on Cardiovascular Drug Discovery Role of Angiotensin-1-Receptor Blockers In Cardiorenal Disease
Current Drug Therapy Lipid Profile of Children Suffering from Pediatric Rheumatic Diseases (pRDS)
Current Rheumatology Reviews Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment
Current Pharmaceutical Biotechnology Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)
Current Signal Transduction Therapy Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia
Current Pharmaceutical Design Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)